Literature DB >> 23895893

Hypertrophic cardiomyopathy: prognostic factors and survival analysis in 128 Egyptian patients.

Sonia A El-Saiedi1, Zeinab S Seliem1, Reem I Esmail1.   

Abstract

BACKGROUND: Hypertrophic cardiomyopathy is an important cause of disability and death in patients of all ages. Egyptian children may differ from Western and Asian patients in the pattern of hypertrophy distribution, clinical manifestations, and risk factors.
OBJECTIVES: The aim of our study was to report the clinical characteristics and outcomes of Egyptian children with hypertrophic cardiomyopathy studied over a 7-year duration and to determine whether the reported adult risk factors for sudden cardiac death are predictive of the outcome in these affected children. STUDY DESIGN AND METHODS: This retrospective study included 128 hypertrophic cardiomyopathy children. The data included personal history, family history, physical examination, baseline laboratory measurements, electrocardiogram, and Holter and echocardiographic results. Logistic regression analysis was used for the detection of risk factors of death.
RESULTS: Fifty-one out of 128 patients died during the period of the study. Of the 51 deaths, 36 (70.5%) occurred in patients presenting before 1 year of age. Only eight patients had surgical intervention. Extreme left ventricular hypertrophy, that is, interventricular septal wall thickness or posterior wall thickness Z-score >6, sinus tachycardia, and supraventricular tachycardia were found to be independent risk factors for prediction of death in patients with hypertrophic cardiomyopathy.
CONCLUSIONS: At our Egyptian tertiary care centre, hypertrophic cardiomyopathy has a relatively worse prognosis when compared with reports from Western and Asian series. Infants have a worse outcome than children presenting after the age of 1 year. A poorer prognosis in childhood hypertrophic cardiomyopathy is predicted by an extreme left ventricular hypertrophy, the presence of sinus tachycardia, and supraventricular tachycardia.

Entities:  

Mesh:

Year:  2013        PMID: 23895893     DOI: 10.1017/S1047951113001030

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  8 in total

1.  Delayed Myocardial Enhancement in Pediatric Hypertrophic Cardiomyopathy: Correlation with LV Function, Echocardiography, and Demographic Parameters.

Authors:  Sonia El Saiedi; Noha Hossam Behairy; Ahmed Kharabish; Reem Esmail; Zeinab Salah Seliem; Mervat Shafik; Wesam El Mozy
Journal:  Pediatr Cardiol       Date:  2017-04-11       Impact factor: 1.655

Review 2.  Research priorities in sarcomeric cardiomyopathies.

Authors:  Jolanda van der Velden; Carolyn Y Ho; Jil C Tardiff; Iacopo Olivotto; Bjorn C Knollmann; Lucie Carrier
Journal:  Cardiovasc Res       Date:  2015-01-28       Impact factor: 10.787

3.  The association between brain natriuretic peptide and tissue Doppler parameters in children with hypertrophic cardiomyopathy.

Authors:  Taliha Öner; Rahmi Özdemir; Filiz Hazan; Cem Karadeniz; Önder Doksoz; Murat Muhtar Yilmazer; Timur Meşe; Vedide Tavli
Journal:  Bosn J Basic Med Sci       Date:  2016-01-01       Impact factor: 3.363

Review 4.  Targets for therapy in sarcomeric cardiomyopathies.

Authors:  Jil C Tardiff; Lucie Carrier; Donald M Bers; Corrado Poggesi; Cecilia Ferrantini; Raffaele Coppini; Lars S Maier; Houman Ashrafian; Sabine Huke; Jolanda van der Velden
Journal:  Cardiovasc Res       Date:  2015-01-29       Impact factor: 10.787

5.  I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model.

Authors:  Felix W Friedrich; Hannieh Sotoud; Birgit Geertz; Silvio Weber; Frederik Flenner; Silke Reischmann; Thomas Eschenhagen; Lucie Carrier; Ali El-Armouche
Journal:  Int J Cardiol Heart Vasc       Date:  2015-05-29

Review 6.  Risk stratification in childhood hypertrophic cardiomyopathy.

Authors:  Gabrielle Norrish; Juan Pablo Kaski
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

7.  Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy.

Authors:  Gabrielle Norrish; Tao Ding; Ella Field; Elena Cervi; Lidia Ziółkowska; Iacopo Olivotto; Diala Khraiche; Giuseppe Limongelli; Aris Anastasakis; Robert Weintraub; Elena Biagini; Luca Ragni; Terrence Prendiville; Sophie Duignan; Karen McLeod; Maria Ilina; Adrián Fernández; Chiara Marrone; Regina Bökenkamp; Anwar Baban; Peter Kubus; Piers E F Daubeney; Georgia Sarquella-Brugada; Sergi Cesar; Sabine Klaassen; Tiina H Ojala; Vinay Bhole; Constancio Medrano; Orhan Uzun; Elspeth Brown; Ferran Gran; Gianfranco Sinagra; Francisco J Castro; Graham Stuart; Gabriele Vignati; Hirokuni Yamazawa; Roberto Barriales-Villa; Luis Garcia-Guereta; Satish Adwani; Katie Linter; Tara Bharucha; Pablo Garcia-Pavia; Ana Siles; Torsten B Rasmussen; Margherita Calcagnino; Caroline B Jones; Hans De Wilde; Toru Kubo; Tiziana Felice; Anca Popoiu; Jens Mogensen; Sujeev Mathur; Fernando Centeno; Zdenka Reinhardt; Sylvie Schouvey; Costas O'Mahony; Rumana Z Omar; Perry M Elliott; Juan Pablo Kaski
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-05-02

8.  Study on Risk Factors for Death from Cardiomyopathy and Effectiveness of Health Information Management.

Authors:  Lei Wang; Shuping Zhang; Yan Wang; Jin Xuan; Yanli Han; Jianlin Ke
Journal:  J Healthc Eng       Date:  2021-12-07       Impact factor: 2.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.